Radioguided sentinel lymph node biopsy in breast cancer surgery

Journal of Nuclear Medicine

Volumn 42, Issue 8, 2001, Pages 1198-1215

  Mariani, G ^a   Moresco, L ^a   Viale, G ^a   Villa, G ^a   Bagnasco, M ^a   Canavese, G ^a   Buscombe, J ^a   Strauss, H W ^a   Paganelli, G ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Breast cancer; Interstitial administration; Intraoperative probe guidance; Lymphoscintigraphy; Radiocolloid; Sentinel lymph node

Indexed keywords

ANTIBODY; ANTIMONY TECHNETIUM SULFIDE TC 99M; COLLOID TC 99M; CYTOKERATIN; DEXTRAN TC 99M; DYE; GOLD 198; HUMAN SERUM ALBUMIN TC 99M; PHYTATE TECHNETIUM TIN TC 99M; RADIOPHARMACEUTICAL AGENT; RHENIUM SULFIDE COLLOID TC 99M; STANNOUS FLUORIDE; TECHNETIUM SULFUR COLLOID TC 99M; TRACER;

ARTICLE; BREAST CANCER; CANCER SURGERY; CORRELATION FUNCTION; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MORBIDITY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; VITAL STAIN;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC SYSTEM; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY;

EID: 0034894472     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (151)

1. Lectures on the lymphatic system of the stomach
2. Observations on a "sentinel node" in cancer of the parotid
3. An approach to the treatment of penile carcinoma
4. A rational approach to the surgical management of melanoma
5. Internal mammary lymphoscintigraphy in breast carcinoma: A study of 1072 patients
6. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers
7. Historical perspective of lymphatic turnout spread and the emergence of the sentinel node concept
8. Lymphatic mapping and sentinel lymph node biopsy in breast cancer
9. Sentinel lymph node detection and imaging
10. The concept of sentinel node localization: How it started
11. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe
12. Intraoperative lymphatic mapping and sentinel node identification: Gynecologic applications
13. Present and future of sentinel node lymphadenectomy in breast cancer
14. Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer
15. Technical details of intraoperative lymphatic mapping for early stage melanoma
16. Gamma probe guided lymph node localization in malignant melanoma
17. Gamma-probe-guided lymph node localization in malignant melanoma
18. Lymphoscintigraphy in high-risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node
19. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
20. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
21. Metastasis via the lymphatics
22. Lymphatic metastasis
23. The orderly progression of melanoma nodal metastases
24. Controversies in sentinel node biopsy for breast cancer
25. Tumor-related prognostic factors for breast cancer
26. Significance of axillary lymph node metastasis in primary breast cancer
27. Non-palpable lesions of the breast detected by mammography: Review of 1182 consecutive histologically confirmed cases
28. New era in breast cancer: Impact of screening on disease presentation
29. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
30. Extent of metastatic axillary involvement in 1446 cases of breast cancer
31. Axillary lymph node dissection for T1a breast carcinoma: Is it indicated?
32. Axillary lymph node dissection: Is it required in T1a breast cancer?
33. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes
34. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast
35. The natural history of breast carcinoma: What have we learned from screening?
36. Rationale for routine axillary dissection in carcinoma of the breast
37. Case against axillary lymphadenectomy for most patients with infiltrating breast cancer
38. Is axillary dissection necessary for T1 carcinoma of the breast?
39. Sentinel lymphadenectomy and breast cancer
40. Reappraisal of the role of axillary lymph node dissection in conservative treatment of breast cancer
41. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
42. Breast carcinoma
43. Axillary dissection in breast cancer: When, why, how much, and for how long? - Another operation soon to be extinct?
44. Axillary lymph nodes and breast cancer
45. Addressing the axilla in breast cancer: 1998
46. Lymph node micrometastases from breast carcinoma: Reviewing the dilemma
47. Serial sectioning of sentinel nodes in patients with breast cancer: A pilot study
48. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
49. The need to reexamine axillary lymph node dissection in invasive breast cancer
50. Meeting highlights: International consensus panel on the treatment of primary breast cancer
51. The role of axillary dissection in mammographically detected carcinoma
52. Critical evaluation of prognostic factors
53. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
54. Management of the axilla in early-stage breast cancer
55. Lymph node metastases: Indicators, but not governors of survival
56. Patients with early breast cancer benefit from effective axillary treatment
57. Prognosis of breast cancer with axillary node metastases after surgical treatment only
58. Total axillary dissection in the management of breast cancer
59. Axillary node dissection for early breast cancer: Some is good, but all is better
60. Role of axillary dissection in breast cancer management
61. Axillary lymphadenectomy: A diagnostic and therapeutic procedure
62. The dissection of mammary nodes does not improve the survival of breast cancer patients: 30 Years of a randomized trial
63. Should internal mammary nodes be samples in the sentinel lymph node era?
64. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation
65. The impact of prophylactic axillary node dissection on breast cancer survival: A Bayesian meta-analysis
66. Improved axillary staging of breast cancer with sentinel lymphadenectomy
67. Clinical relevance of serial sectioning of sentinel nodes and the detection of micrometastatic nodal disease in breast cancer
68. The structure and functioning of the blood vessels, interstitial tissues and lymphatics
69. New techniques of demonstrating lymph vessels in skin biopsy specimens and intact skin with the scanning electron microscope
70. Recent findings on the angioarchitecture of the lymph vessel system of human skin
71. Normal and tumor angiogenesis related to flow
72. In vivo evidence of lymphovenous communications in the popliteal region
73. The clinical significance of lympho-venous anastamoses in malignant disease
74. The lymphatics of the breast
75. On the origin and progression of human breast cancer
76. Breast development and anatomy
77. Molecular biology of cancer
78. Clinical applications of research on angiogenesis
79. Angiogenesis and tumor growth
80. Prognostic significance of microvessel density in lymph node negative breast carcinoma
81. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
82. On tumor (and other) lymphangiogenesis
83. The "critical colloid dose" in studies of reticuloendothelial function
84. Sentinel node localization in cutaneous melanoma: Lymphoscintigraphy with colloids and antibody fragments versus blue dye mapping
85. Differential properties of organ-specific serum opsonins for liver and spleen macrophages
86. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes
87. Factors affecting distribution of technetiumsulfur colloid
88. Particle sizing and biokinetics of interstitial lympho-scintigraphic agents
89. Radiolabeled colloids and macromolecules in the lymphatic system
90. Mechanism of colloid uptake into the lymphatic system: Basic study with percutaneous lymphography
91. Radiopharmaceutical chemistry
92. 99mTc-labeled and unlabeled antimony trisulfide and rhenium sulfide colloids intended for lymphoscintigraphic application
93. Radiopharmaceuticals in sentinel lymph-node detection: An overview
94. Radiopharmaceuticals for lymphoscintigraphy: Including dosimetry and radiation considerations
95. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer
96. Validation of gamma probe detection of the sentinel node in melanoma
97. Quantitative lymphoscintigraphy: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits
98. 99mTc-labeled dextran
99. Optimized sentinel node scintigraphy in breast cancer
100. Sentinel lymph node biopsy in breast cancer: Unfiltered radioisotope is superior to filtered
101. State-of-the-art approaches to sentinel node biopsy for breast cancer: Study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center
102. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
103. Intradermal blue dye to identify sentinel lymph node in breast cancer
104. Subareolar versus peritumoral injection for location of the sentinel lymph node
105. In search of the true sentinel node by different injection techniques in breast cancer patients
106. Functional lymphatic anatomy in breast cancer: Echoes from the past and the periareolar blue method
107. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients
108. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes
109. Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patient
110. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer
111. Lymphoscintigraphy and sentinel node localization in breast cancer patients: A comparison between 1-day and 2-day protocols
112. Sentinel lymph node biopsy: Strategies for pathologic examination of the specimen
113. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients
114. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma
115. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma
116. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients
117. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction
118. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction: Comparison between MUCI mRNA and keratin 19 mRNA amplification
119. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
120. Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue-dye and intraoperative gamma-probe
121. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer
122. Long-term results for a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial
123. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy
124. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer
125. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer
126. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy
127. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma
128. Gammaprobe sentinel node localisation and biopsy in breast cancer patients treated with neoadjuvant chemotherapy scheme
129. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye
130. The sentinel node in breast cancer: A multicenter validation study
131. The learning curve for sentinel node biopsy in breast cancer: Practical considerations
132. Credentialing for breast lymphatic mapping: How many cases are enough?
133. The role of sentinel lymph node biopsy in breast cancer
134. 2 surgical probes: Physical characterization
135. 2 surgical probes: Effect of scatter compensation on probe performance
136. Evaluation of surgical gamma probes for radioguided sentinel node localization
137. A method to evaluate intra-operative gamma probes for sentinel lymph node localisation
138. Intraoperative probes
139. The intraoperative gamma probe: Basic principles and choices available
140. Radiation protection in radioguided surgery of breast cancer
141. Sentinel node localization in breast cancer
142. Guidelines for safe use of radioactive materials during localization and resection of the sentinel lymph node
143. Radiation safety with breast sentinel node biopsy
144. Radioguided surgery of breast cancer: Radiation protection survey
145. Radiation safety of the sentinel lymph node technique in breast cancer
146. Lymphatic system
147. Current status of commercial colloidal preparations for sentinel lymph node detection